| abstract |
Pharmaceutical composition effective in reducing damage to neurons due to an ischemic state in a mammalian species. The composition comprises a neural calcium channel blocker compound, effective in blocking norepinephrine in neuronal cells of the mammalian central nervous system, and characterized by specific binding by high affinity, to an omega-conotoxin MVIIA binding protein. New omega-conotoxin peptides are also described. |